Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial.
2024

Effectiveness of Awake Prone Positioning in COVID-19 Patients

Sample size: 93 publication 10 minutes Evidence: low

Author Information

Author(s): Phong Nguyen Thanh, Duc Du Hong, Hai Ho Bich, Nguyen Nguyen Thanh, Khoa Le Dinh Van, Khanh Le Thuy Thuy, Tran Luu Hoai Bao, Linh Nguyen Thi My, Van Cao Thi Cam, Thao Dang Phuong, Trinh Nguyen Thi Diem, Kieu Pham Tieu, Truong Nguyen Thanh, Hoang Vo Tan, Ngoc Nguyen Thanh, Vien Tran Thi Dong, Ly Vo Trieu, Khoa Tran Dang, Beane Abigail, Anibal James, Thwaites Guy E, Geskus Ronald, Clifton David, Dung Nguyen Thi Phuong, Kestelyn Evelyne, Glover Guy, Tan Le Van, Yen Lam Minh, Tung Nguyen Le Nhu, Dung Nguyen Thanh, Thwaites C Louise

Primary Institution: Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Hypothesis

Does awake prone positioning improve respiratory support outcomes in moderate to severe COVID-19 patients?

Conclusion

Awake prone positioning did not show a benefit in reducing the need for respiratory support, but it was safe and well-accepted by patients.

Supporting Evidence

  • 93 patients were enrolled in the study between March 2022 and March 2023.
  • Patients reported that prone positioning was comfortable, although most preferred to lie on their back.
  • Continuous monitoring with wearable devices was feasible and acceptable for patients.
  • Significantly greater mean daily prone positioning times were achieved in the APP group.

Takeaway

Lying on your stomach might help some sick patients breathe better, but in this study, it didn't make a big difference for those who needed extra help with breathing.

Methodology

This was an open-label, randomized controlled trial conducted in a tertiary hospital, comparing standard care to awake prone positioning with continuous monitoring.

Potential Biases

Potential bias due to the single-center design and early termination of the study.

Limitations

The study was terminated early due to a reduction in eligible patients, leading to a smaller sample size than planned.

Participant Demographics

Adults (≥18 years) hospitalized with moderate to severe COVID-19, with 86% having received at least two doses of the SARS-CoV2 vaccine.

Statistical Information

P-Value

0.67

Confidence Interval

0.40-1.78

Statistical Significance

p=0.67

Digital Object Identifier (DOI)

10.12688/wellcomeopenres.22792.2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication